Back

Association between implanted cardioverter-defibrillator and mortality for patients with left ventricular ejection fraction near 35%

25 August 2023 (16:15 - 16:50)
Organised by: Logo
Congress Presentation Part of: Devices and heart failure: ICD and CRT Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Jason Wasfy

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Efficacy of implantable cardioverter-defibrillator in non-ischemic systolic heart failure in patients with and without chronic kidney disease: an extended follow-up analysis of the DANISH trial
Doctor S. N Doi (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
A systematic review of Australian hospitals' policies on the deactivation of implantable cardioverter defibrillators
Doctor D. Grose (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Effect of implantable cardioverter-defibrillator in non-ischaemic systolic heart failure according to the Heart Failure Collaboratory Medical Therapy Score: extended follow-up of the DANISH trial
Doctor A. Yafasova (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Left bundle branch area pacing in patients with CRT indication: short-term results & 1-year follow-up
Doctor V. Kataria (New Delhi, IN)
Abstract Slides
Presentation thumbnail
Role of fragmented QRS complex in the prognosis of patients undergoing cardiac resynchronization therapy. A new red flag to look for?
Doctor C. Rodriguez-Lopez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Devices and heart failure: ICD and CRT

The Event

Event poster

ESC Congress 2023

25 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Competing risks of ventricular tachyarrhythmias and mortality in advanced heart failure: impact of left ventricular ejection fraction
thumbnail
Congress Presentation
Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources